Award
National Cancer Institute 5U01CA286811-03
Assessing benefits and harms of cannabis use in patients treated with immunotherapy for cancer: a prospective cohort study
Recipient
Not specified
Award Amount
$629,354.00
Ceiling
$629,354.00
Awarded
August 20, 2025
Identifier
5U01CA286811-03
A NIH/NCI funded prospective cohort study assessing the benefits and harms of cannabis use in cancer patients treated with immunotherapy, focusing on long-term effects and disease progression.
Description
This project aims to evaluate the benefits and harms of cannabis use among cancer patients undergoing immunotherapy, focusing on long-term effects, immune function, and disease progression. It involves a multi-site, 12-month prospective cohort with assessments via ecological momentary assessment, patient surveys, and electronic medical records. Funded by NIH/NCI to improve cancer symptom management and patient safety.